(Q43541493)

24 November 2017

title

Ischaemic colitis in a patient taking meloxicam (English)

1 reference

ORCID Public Data File 2021

24 November 2017

1 reference

author name string

B Garcia

1

1 reference

24 November 2017

F Ramaholimihaso

2

1 reference

24 November 2017

M D Diebold

3

1 reference

24 November 2017

G Cadiot

4

1 reference

24 November 2017

G Thiéfin

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

357

1 reference

24 November 2017

issue

9257

1 reference

24 November 2017

page(s)

690

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904141-6

24 November 2017

1 reference

7 January 2021

A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904141-6

Crossref

reference URL

7 January 2021

COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904141-6

Crossref

reference URL

7 January 2021

Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904141-6

Crossref

reference URL

7 January 2021

10.1016/S0140-6736(00)04141-6

Identifiers

DOI

1 reference

24 November 2017

1 reference